BHC vs ECL · rev $9.63B vs P/E 35, rev $4.01B
Bausch Health Companies Inc (BHC) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Bausch Health Companies Inc (BHC) is a drug manufacturers - specialty & generic company listed on NYSE.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BHC revenue for 2024-12-31 was $9.63B. Net income was -$72.0M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. BHC currently screens at market cap $1.78B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BHC currently screens at market cap $1.78B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BHC and ECL stock pages for the full models.
Not investment advice.